Search
OriCar-017
go.drugbank.com/drugs/DB17280InvestigationalSynonyms: GPRC5D-CAR-T, chimeric antigen receptor (CAR)-T cell therapy targeting G protein-coupled receptor class-C group-5 member-D (GPRC5D)Medronic acid
go.drugbank.com/drugs/DB14078ApprovedInvestigationalProducts: MON MDP KIT 10 MG IV ENJEKSİYON İÇİN LİYOFİLİZE TOZ İÇEREN FLAKON, 5 ADETZamtocabtagene autoleucel
go.drugbank.com/drugs/DB18764InvestigationalSynonyms: Autologous pLTG1497-transduced CAR T cells MB-CART2019.1, Autologous anti-CD20/CD19-targeting tandem CAR T cells MB-CART2019.1Anastrozole
go.drugbank.com/drugs/DB01217ApprovedInvestigational[L8863] Anastrozole is also related to [exemestane], a steroidal AI, but its non-steroidal nature provides stark advantages including a lack of steroid-associated adverse effects such as weight gain and … [A186865] Aromatase inhibitors, including anastrozole, have become endocrine drugs of choice in the treatment of postmenopausal breast cancer due to a more favourable efficacy and adverse effect profile
Categories: Antineoplastic and Immunomodulating Agents, Hormone Antagonists and Related AgentsProducts: ANANA® 1 MG TABLETA CUBIERTA CON PELICULA, Van-anastrozoleSacubitril
go.drugbank.com/drugs/DB09292ApprovedInvestigationalIt was approved by the FDA after being given the status of priority review for on July 7, 2015. … Sacubitril is a prodrug neprilysin inhibitor used in combination with valsartan to reduce the risk of cardiovascular events in patients with chronic heart failure (NYHA Class II-IV) and reduced ejection
Mixtures: ENTRESTO FILM COATED TABLET 50MG, Uperio 50mg Film-coated TabletsCategories: valsartan and sacubitril, Amino Acids, Peptides, and ProteinsPostpartum uterine subinvolution
go.drugbank.com/conditions/DBCOND0018185Drugs: MethylergometrineSynonyms: Subinvolution of uterus in the puerperium, Subinvolution of uterus in puerperium (disorder)Urolithiasis
go.drugbank.com/conditions/DBCOND0032691Drugs: beta-PineneSynonyms: Urolith in urinary systemTradipitant
go.drugbank.com/drugs/DB12580ApprovedInvestigational[L54903] NK-1 receptors are expressed in the brainstem and nucleus tractus solitarius, which receives emetogenic signals from various stimuli including dizziness and vertigo. … [A275353] Approved by the FDA on December 30, 2025, tradipitant is indicated for the prevention of vomiting induced by motion.
Viloxazine
go.drugbank.com/drugs/DB09185ApprovedInvestigationalWithdrawnIt was first approved in the UK in 1974; however, the immediate-release formulation was discontinued due to business reasons unrelated to drug safety and efficacy. … In the US, viloxazine was assigned an orphan drug designation in 1984 under the brand name CATATROL: while this product was intended to treat cataplexy and narcolepsy, the drug was never approved for these